Medical Condition News

RSS

The AFA completes yearlong fertility educational series

The American Fertility Association is pleased to announce the completion of a yearlong fertility educational series which was funded by Attain Fertility Centers.

30 Apr 2011

Opinions: NCDs must be tackled worldwide; myths surround usefulness of foreign aid

Jake Marcus, a post-bachelor fellow at the Institute for Health Metrics and Evaluation, examines why non-communicable diseases have been a neglected part of global health care in a New Republic opinion piece.

30 Apr 2011

WAST NHS to equip its frontline ambulances with ZOLL E Series EMS monitor/defibrillator

ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that the Welsh Ambulance Services NHS is equipping its frontline ambulances with the ZOLL E Series EMS monitor/defibrillator.

30 Apr 2011

People with Alzheimer's, cardiovascular risk gene experience early memory decline

People who carry a gene associated with Alzheimer's disease and have cardiovascular risks experience age-related memory decline 20 to 25 years sooner than people who carry the gene without cardiovascular risk according to a 17-year Mayo Clinic-led study recently published in Neurology.

30 Apr 2011

ATRN experts to improve health in Appalachian region

According to the Centers for Disease Control and Prevention, residents of many Appalachian counties are three times more likely to die from diabetes than someone living in other counties in the same state, or in most other parts of the United States. Now, a group of seven regional academic centers and community organizations have joined forces to change those health disparities and improve health through the creation of the Appalachian Translational Research Network.

30 Apr 2011

University of South Florida researcher earns Everfront Award for stem cell study

Dr. Paul Sanberg, Distinguished University Professor and senior associate vice president for research and innovation at the University of South Florida, received the Everfront Award at the 4th Pan Pacific Symposium on Stem Cell and Cancer Research held earlier this month in Taichung, Taiwan.

30 Apr 2011

Health Canada approves Eli Lilly's Cymbalta for chronic low back pain treatment

Eli Lilly Canada announced today that Health Canada has approved Cymbalta for the management of chronic low back pain.

30 Apr 2011

Study explores link between primary healthcare provider and patient activation

People with a chronic condition such as diabetes or arthritis may find themselves taking on a more active role in maintaining or improving their own health if there is an ongoing relationship with a primary healthcare provider, according to University of British Columbia research.

30 Apr 2011

New guide to help cancer patients manage symptoms, side effects

Cancer patients can be hit with a nasty array of symptoms and side effects, from anemia and anxiety to hair loss and hot flashes. Some of these problems can be so overwhelming that they cause patients to abandon life-saving treatments.

30 Apr 2011

IMPAKT 2011 conference to highlight new breast cancer studies

"The presentations at this year's IMPAKT reveal the innovative and diverse approaches that investigators are taking to identify the most encouraging new agents both before clinical evaluation and in early clinical studies. These range from ideas for novel clinical designs to the development of more sensitive and specific biomarkers and to data sharing that allows a more objective assessment of compounds prior to commitment of major clinical resources."

30 Apr 2011

ETP makes investment to support development of ICVrx's targeted epilepsy drug technology

Epilepsy Therapy Project, a non-profit organization whose mission is to accelerate new therapies for people living with epilepsy and seizures, and ICVrx, LLC, a pharmacy product research and development company focused on novel therapies for central nervous system disorders, announced today that ETP has made an investment in ICVrx to support the development of ICVrx's targeted epilepsy drug technology for patients whose seizures are not controlled by current therapies.

30 Apr 2011

Gene therapy approach using CD59 shows promise against AMD: Study

A gene therapy approach using a protein called CD59, or protectin, shows promise in slowing the signs of age-related macular degeneration, according to a new in vivo study by researchers at Tufts University School of Medicine.

30 Apr 2011

CEL-SCI receives no objection letter to initiate Phase III clinical trial of Multikine in Canada

CEL-SCI Corporation announced today that the Biologics and Genetic Therapeutics Directorate of Health Canada has issued a final "no objection" letter for CEL-SCI to be able to begin enrollment of patients for a Phase III clinical trial of Multikine in Canada.

30 Apr 2011

DVA is now DaVita Labs

Operating as a division of DaVita Inc., a leading provider of kidney care services for those diagnosed with end stage renal disease and chronic kidney disease, DVA Laboratory Services announced its new company name, DaVita Labs.

30 Apr 2011

Black cardiac arrest victims less apt to survive at hospitals: Study

Black cardiac arrest victims are more likely to die when they're treated in hospitals that care for a large black population than when they're brought to hospitals with a greater proportion of white patients, according to new research from the University of Pennsylvania School of Medicine.

30 Apr 2011

FDA approves Abbott's AndroGel for hypogonadism treatment in men

Abbott announced today that the U.S. Food and Drug Administration has approved AndroGel 1.62%, a clear, odorless, gel formulation shown to restore testosterone levels in hypogonadal men with half the volume of gel at the starting dose compared to AndroGel 1%.

30 Apr 2011

Spectrum receives FDA approval for FUSILEV to treat colorectal cancer

Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, received approval from the U.S. Food and Drug Administration on April 29, 2011, for the use of FUSILEV in combination with 5-fluorouracil in the palliative treatment of patients with advanced metastatic colorectal cancer.

30 Apr 2011

Improved body armor needed to protect brain from 'shell shock' injuries

Stronger and tougher body armor to shield the chest, abdomen and back may be just what soldiers fighting in the Afghanistan and Iraq wars need to better protect their brains from mild injuries tied to so-called "shell shock," results of a Johns Hopkins study in mice suggest.

29 Apr 2011

Health Canada grants SQI license to market IgX PLEX Celiac Panel

SQI Diagnostics Inc., a medical systems automation company focused on evolving laboratory-based autoimmune biomarker testing, today announced it has received a license from Health Canada permitting the Company to market its IgX PLEX™ Celiac Panel, a quantitative 4-plex panel, which will run on SQI's automated SQiDworks™ Diagnostics Platform.

29 Apr 2011

Sorin launches XTRA autotransfusion system

Sorin Group, a global medical device company and a leader in the treatment of cardiovascular diseases, is proud to announce the launch in the U.S. of XTRA, the next-generation of Sorin's autotransfusion (ATS) device family.

29 Apr 2011